Table 3 Follow-up outcomes
Group I (n = 36) | Group II (n = 73) | P value | |
|---|---|---|---|
Mean follow-up Period, months | 16.7 ± 9.8 | 23.0 ± 7.2 | 0.000 |
All-cause death, n (%) | 1 (2.8%) | 2 (2.7%) | 1.000 |
Cardiovascular death, n (%) | 1 (2.8%) | 0 (0%) | 0.330 |
Non-cardiovascular death, n (%) | 0 (0%) | 2 (2.7%) | 1.000 |
Stroke/TIA, n (%) | 1 (2.8%) | 4 (5.5%) | 1.000 |
System embolism, n (%) | 0 (0%) | 1 (1.4%) | 1.000 |
All-bleeding, n (%) | 2 (5.6%) | 3 (4.1%) | 1.000 |
Major bleeding, n (%) | 0 (0%) | 2 (2.7%) | 1.000 |
Gastrointestinal bleeding, n (%) | 0 (0%) | 2 (2.7%) | 1.000 |
Cerebral hemorrhage, n (%) | 1 (2.8%) | 0 (0%) | 0.330 |
Other bleeding, n (%) | 1 (2.8%) | 1 (1.4%) | 1.000 |
Device thrombus, n (%) | 3 (8.3%) | 1 (1.4%) | 0.104 |
Heart failure, n (%) | 2 (5.6%) | 6 (8.2%) | 1.000 |
Cancer, n (%) | 2 (5.6%) | 3 (4.1%) | 1.000 |
Peri-device leak (> 5 mm), n (%) | 0 (0%) | 0 (0%) | 1.000 |